Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1957 1
1959 1
1963 1
1964 1
1968 1
1969 3
1970 1
1971 1
1973 4
1979 1
1980 1
1983 1
1984 1
1985 4
1987 1
1990 1
1991 2
1992 1
1993 1
1994 1
1995 1
1996 2
1997 3
1998 3
1999 2
2000 5
2001 1
2002 5
2003 1
2004 2
2005 3
2006 6
2007 5
2008 6
2009 5
2010 3
2011 4
2012 5
2013 6
2014 7
2015 8
2016 11
2017 12
2018 5
2019 3
2020 10
2021 9
2022 10
2023 15
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.
Martin KA, Lee CR, Farrell TM, Moll S. Martin KA, et al. Am J Med. 2017 May;130(5):517-524. doi: 10.1016/j.amjmed.2016.12.033. Epub 2017 Feb 1. Am J Med. 2017. PMID: 28159600 Free PMC article. Review.
Bariatric surgery may alter the absorption, distribution, metabolism, or elimination (disposition) of orally administered drugs via changes to the gastrointestinal tract anatomy, body weight, and adipose tissue composition. As some patients who have undergone …
Bariatric surgery may alter the absorption, distribution, metabolism, or elimination (disposition) of orally administered drugs via changes …
[Anticoagulation-direct oral anticoagulants].
Kemkes-Matthes B. Kemkes-Matthes B. Internist (Berl). 2017 Jun;58(6):585-597. doi: 10.1007/s00108-017-0243-y. Internist (Berl). 2017. PMID: 28536761 Review. German.
Since direct oral anticoagulants (DOAC) have become available, use of anticoagulant treatment has become easier and safer-for patients suffering from thromboembolic diseases as well as for patients with atrial fibrillation: Because of constant bioavailability, fixed dose regimen …
Since direct oral anticoagulants (DOAC) have become available, use of anticoagulant treatment has become easier and safer-for patients suffe …
Anticoagulation at the extremes of body weight: choices and dosing.
McCaughan GJB, Favaloro EJ, Pasalic L, Curnow J. McCaughan GJB, et al. Expert Rev Hematol. 2018 Oct;11(10):817-828. doi: 10.1080/17474086.2018.1517040. Epub 2018 Sep 25. Expert Rev Hematol. 2018. PMID: 30148651 Review.
However, the optimal anticoagulant agent and dosing strategy for patients at both extremes of body weight has not been established for any anticoagulant, including DOACs, vitamin K antagonists (VKA), and the various heparin options. Areas covered: This …
However, the optimal anticoagulant agent and dosing strategy for patients at both extremes of body weight has not been establi …
Effect of Body Weight on Dose of Vitamin K Antagonists.
Self TH, Wallace JL, Sakaan S, Sands CW. Self TH, et al. South Med J. 2015 Oct;108(10):637-43. doi: 10.14423/SMJ.0000000000000356. South Med J. 2015. PMID: 26437201 Review.
OBJECTIVES: Numerous factors are well documented to affect the response to vitamin K antagonists (VKA), including dietary vitamin K, other drugs, age, pharmacogenetics, and disease states. Body weight is perhaps not as well known as a var …
OBJECTIVES: Numerous factors are well documented to affect the response to vitamin K antagonists (VKA), including dietary v …
Effect of diseases on response to vitamin K antagonists.
Self TH, Owens RE, Sakaan SA, Wallace JL, Sands CW, Howard-Thompson A. Self TH, et al. Curr Med Res Opin. 2016;32(4):613-20. doi: 10.1185/03007995.2015.1134464. Epub 2016 Jan 25. Curr Med Res Opin. 2016. PMID: 26695107 Review.
METHODS: We searched the English literature from 1946 to September 2015 via PubMed, EMBASE, and Scopus for the effect of diseases on response vitamin K antagonists including warfarin, acenocoumarol, phenprocoumon, and fluindione. ...Hypothyroidism is associated with …
METHODS: We searched the English literature from 1946 to September 2015 via PubMed, EMBASE, and Scopus for the effect of diseases on respons …
Non-Vitamin K Antagonist Oral Anticoagulant for Atrial Fibrillation in Obese Patients.
Wang SY, Giugliano RP. Wang SY, et al. Am J Cardiol. 2020 Jul 15;127:176-183. doi: 10.1016/j.amjcard.2020.04.016. Epub 2020 Apr 23. Am J Cardiol. 2020. PMID: 32423697 Review.
Four non-vitamin K antagonist oral anticoagulants (NOACs) are approved for use to reduce the risk of stroke and systemic embolism in patients with atrial fibrillation (AF). ...The Pubmed database was searched for relevant articles. When evaluating obese patie …
Four non-vitamin K antagonist oral anticoagulants (NOACs) are approved for use to reduce the risk of stroke and systemic embol …
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients.
Ravera M, Nickolas T, Plebani M, Iervasi G, Aghi A, Khairallah P, Gallieni M, Mereu MC, Giannini S, Sella S, Zaninotto M, Paoletti E, Bussalino E, Di Lullo L, Bellasi A, Cosmai L, Foramitti M, Malberti F, Brandi ML, Ferrari S, Tripepi G, Fusaro M. Ravera M, et al. Clin Chem Lab Med. 2020 May 8;59(3):581-589. doi: 10.1515/cclm-2020-0194. Print 2021 Feb 23. Clin Chem Lab Med. 2020. PMID: 32383688 Free article.
Bone Gla protein (BGP) is involved both in bone mineralization and VCs. We assessed the relationships between vitamin K levels and body mass index (BMI) according to the hypothesis that the impact of BMI on mortality is partly driven by low vitamin K l …
Bone Gla protein (BGP) is involved both in bone mineralization and VCs. We assessed the relationships between vitamin K levels …
Response of human beings to vitamin K 1.
[No authors listed] [No authors listed] Nutr Rev. 1969 Oct;27(10):287-9. doi: 10.1111/j.1753-4887.1969.tb03651.x. Nutr Rev. 1969. PMID: 4901122 Review. No abstract available.
Anticoagulation and BMI: effect of high body weight on the safety and efficacy of direct oral anticoagulants.
Mausteller KG, Eisele CD, Julian K, Patel P, Bansal A, Jain R, Jain R. Mausteller KG, et al. Future Cardiol. 2022 Sep;18(10):829-837. doi: 10.2217/fca-2021-0146. Epub 2022 Sep 2. Future Cardiol. 2022. PMID: 36052844 Review.
Obesity is an epidemic with rising prevalence, and obese patients are predisposed to comorbid conditions that increase risk for thromboembolic events. ...This review describes recent studies on the pharmacokinetics, safety and efficacy, and clinical outcomes of the …
Obesity is an epidemic with rising prevalence, and obese patients are predisposed to comorbid conditions that increase risk fo …
169 results